TY - JOUR
T1 - Practice of oxygenation and respiratory support during fibreoptic bronchoscopy
T2 - the OxyFOB study protocol
AU - OxyFOB study group
AU - Longhini, Federico
AU - Crimi, Claudia
AU - Noto, Alberto
AU - Pelaia, Corrado
AU - Karakurt, Zuhal
AU - Skoczyński, Szymon
AU - Boléo-Tomé, José Pedro
AU - Winck, João Carlos
AU - Esquinas, Antonio M.
AU - Melhorn, James
AU - Corneci, Dan
AU - Pobeha, Pavol
AU - Bosco, Vincenzo
AU - Garofalo, Eugenio
AU - Bruni, Andrea
AU - Cammarota, Gianmaria
AU - Todorova, Violeta
AU - Puci, Mariangela Valentina
AU - Sotgiu, Giovanni
AU - Kostikas, Konstantinos
AU - Maggiore, Salvatore Maurizio
AU - De Robertis, Edoardo
AU - Ergan, Begum
AU - Landoni, Giovanni
AU - Simonte, Rachele
AU - Nava, Stefano
AU - Navalesi, Paolo
AU - Scala, Raffaele
AU - Gundogus, Baran
AU - Donmez, Gul Erdal
AU - Ernam, Dilek
AU - Campainha, Sergio
AU - Oliveira, Ana
AU - Teixeira, Maria José
AU - Gouveia, Francisco Correia
AU - Monteiro, Catarina Torres
AU - Veske, Nurdan Şimşek
AU - Altın, Sedat
AU - Günlüoğlu, Gülşah
AU - Chousein, Efsun Gonca
AU - Arıkan, Hüseyin
AU - Karakurt, Sait
AU - Lacedonia, Donato
AU - Torraco, Ruggiero
AU - Tondo, Pasquale
AU - Bialka, Szymon
AU - Palaczynski, Piotr
AU - Danel, Justyna
AU - Jankowiak, Piotr
AU - Vaschetto, Rosanna
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025.
PY - 2025/9/2
Y1 - 2025/9/2
N2 - Introduction Flexible bronchoscopy (FB) is widely used for diagnostic and therapeutic procedures in pulmonary medicine. However, FB can cause respiratory and haemodynamic complications, especially in patients with pre-existing lung and/or cardiovascular comorbidities. Despite the range of oxygenation and ventilatory approaches available to prevent these risks, evidence regarding their real-world application and clinical impact is limited. The OxyFOB study aims to assess the prevalence and outcomes of various oxygenation and ventilatory support strategies used during FB across Europe. Methods and analysis The OxyFOB study is a large, prospective, international, observational cohort study which aims to involve over 10 000 FB procedures across European centres. Eligible participants include all adults undergoing FB for diagnostic, therapeutic or procedural indications. Data are collected via a standardised electronic case report form and encompass demographic information, procedural details and clinical outcomes. The primary endpoint is the prevalence of oxygenation and ventilatory support strategies: conventional oxygen therapy, high-flow oxygen therapy, continuous positive airway pressure, non-invasive ventilation and invasive mechanical ventilation. Secondary outcomes include periprocedural respiratory and haemodynamic events, patient comfort, dyspnoea and postprocedural complications. Statistical analyses include descriptive statistics, subgroup comparisons and multivariate logistic regression. Ethics and dissemination The study has received ethical approval from the coordinating centre (protocol n. 22/2022 on the 20 January 2022, by the ‘Comitato Etico Sezione Area Centro - Regione Calabria’) and all participating sites. Informed consent is given from all patients or their legal representatives. Findings will be disseminated through peer-reviewed publications and presentations at international meetings. Data will be managed and made available on reasonable request to support further research.
AB - Introduction Flexible bronchoscopy (FB) is widely used for diagnostic and therapeutic procedures in pulmonary medicine. However, FB can cause respiratory and haemodynamic complications, especially in patients with pre-existing lung and/or cardiovascular comorbidities. Despite the range of oxygenation and ventilatory approaches available to prevent these risks, evidence regarding their real-world application and clinical impact is limited. The OxyFOB study aims to assess the prevalence and outcomes of various oxygenation and ventilatory support strategies used during FB across Europe. Methods and analysis The OxyFOB study is a large, prospective, international, observational cohort study which aims to involve over 10 000 FB procedures across European centres. Eligible participants include all adults undergoing FB for diagnostic, therapeutic or procedural indications. Data are collected via a standardised electronic case report form and encompass demographic information, procedural details and clinical outcomes. The primary endpoint is the prevalence of oxygenation and ventilatory support strategies: conventional oxygen therapy, high-flow oxygen therapy, continuous positive airway pressure, non-invasive ventilation and invasive mechanical ventilation. Secondary outcomes include periprocedural respiratory and haemodynamic events, patient comfort, dyspnoea and postprocedural complications. Statistical analyses include descriptive statistics, subgroup comparisons and multivariate logistic regression. Ethics and dissemination The study has received ethical approval from the coordinating centre (protocol n. 22/2022 on the 20 January 2022, by the ‘Comitato Etico Sezione Area Centro - Regione Calabria’) and all participating sites. Informed consent is given from all patients or their legal representatives. Findings will be disseminated through peer-reviewed publications and presentations at international meetings. Data will be managed and made available on reasonable request to support further research.
UR - https://www.scopus.com/pages/publications/105015315536
U2 - 10.1136/bmjopen-2025-104747
DO - 10.1136/bmjopen-2025-104747
M3 - Article
SN - 2044-6055
VL - 15
JO - BMJ Open
JF - BMJ Open
IS - 9
M1 - e104747
ER -